Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Test Type

  2.3.2 Market Size by Technology

  2.3.3 Market Size by Disorder Type

  2.3.4 Market Size by End User

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

   3.4.1 Reagents, Assay Kits, Consumables, Laboratory Chemicals & Diagnostic Component Suppliers

  3.4.2 Newborn Screening Instrument Manufacturers, Molecular Diagnostics Companies & Testing Solution Providers

  3.4.3 Public Health Laboratories, Hospitals, Screening Centers, Distributors & Service Providers

  3.4.4 Government Health Agencies, Maternity Hospitals, Diagnostic Laboratories & Newborn Screening Program End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Newborn Screening Test & Technology Metrics

4.1.1 Share (%) of newborn screening demand by tandem mass spectrometry, molecular diagnostics, immunoassays, and pulse oximetry technologies globally.

4.1.2 Growth (%) in adoption of next-generation sequencing (NGS) and genetic screening technologies during 2025 and 2026.

4.1.3 Increase (%) in investments toward expanded newborn screening panels and advanced diagnostic capabilities globally.

4.2 Disease Screening & Diagnostic Metrics

4.2.1 Share (%) of newborn screening tests performed for metabolic disorders, endocrine disorders, hemoglobinopathies, cystic fibrosis, and other congenital conditions globally.

4.2.2 Growth (%) in early disease detection programs and mandatory newborn screening initiatives worldwide.

4.2.3 Increase (%) in screening coverage rates and diagnostic follow-up programs globally.

4.3 Healthcare Infrastructure & Public Health Metrics

4.3.1 Share (%) of newborn screening demand generated by public health laboratories, hospitals, and specialized diagnostic centers globally.

4.3.2 Growth (%) in government-supported newborn health and preventive care programs worldwide.

4.3.3 Increase (%) in healthcare expenditure dedicated to maternal and neonatal health services globally.

4.4 Genomics & Precision Medicine Metrics

4.4.1 Share (%) of newborn screening programs incorporating genetic and genomic testing technologies globally.

4.4.2 Growth (%) in precision medicine-driven screening initiatives and rare disease detection programs worldwide.

4.4.3 Increase (%) in adoption of digital health platforms and data management systems supporting newborn screening globally.

4.5 Regional Birth & Screening Program Metrics

4.5.1 Share (%) of global newborn screening demand concentrated across North America, Europe, Asia Pacific, and other regions.

4.5.2 Growth (%) in newborn screening program expansion across emerging economies.

4.5.3 Increase (%) in live birth screening coverage and public health awareness initiatives globally.

5. Newborn Screening Market Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

5.1 Introduction

5.2 Dry Blood Spot Test

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

5.3 Hearing Screening Test

5.4 Critical Congenital Heart Disease Test

6. Newborn Screening Market Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

    6.2 Tandem Mass Spectrometry

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Immunoassays & Enzymatic Assays

 6.4 Hearing Screening Technology

 6.5 DNA Assays & Next-Generation Sequencing

 6.6 Pulse Oximetry

 6.7 Others

7. Newborn Screening Market Analysis & Forecast, By Disorder Type, 2022–2035, Value (USD Billion)

     7.1 Introduction

 7.2 Metabolic Disorders

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Endocrine Disorders

 7.4 Haemoglobin Disorders

 7.5 Immune Deficiency Disorders

 7.6 Others

8. Newborn Screening Market Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

     8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Maternity & Specialty Clinics

 8.4 Diagnostic Centres

9. Newborn Screening Market Analysis & Forecast, By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.2.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Newborn Screening Market Size & Forecast, By Disorder Type, 2022–2035

 9.2.5 Newborn Screening Market Size & Forecast, By End User, 2022–2035

 9.2.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.3.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Newborn Screening Market Size & Forecast, By Disorder Type, 2022–2035

 9.3.5 Newborn Screening Market Size & Forecast, By End User, 2022–2035

 9.3.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.4.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Newborn Screening Market Size & Forecast, By Disorder Type, 2022–2035

 9.4.5 Newborn Screening Market Size & Forecast, By End User, 2022–2035

 9.4.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.5.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Newborn Screening Market Size & Forecast, By Disorder Type, 2022–2035

 9.5.5 Newborn Screening Market Size & Forecast, By End User, 2022–2035

 9.5.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.6.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Newborn Screening Market Size & Forecast, By Disorder Type, 2022–2035

 9.6.5 Newborn Screening Market Size & Forecast, By End User, 2022–2035

 9.6.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Band Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 PerkinElmer Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Bio-Rad Laboratories Inc.

10.6.3 Natus Medical Incorporated

10.6.4 Waters Corporation

10.6.5 SCIEX (Danaher Corporation)

10.6.6 Agilent Technologies Inc.

10.6.7 Masimo Corporation

10.6.8 Baebies Inc.

10.6.9 Covidien PLC (Medtronic)

10.6.10 Chromsystems Instruments & Chemicals GmbH

10.6.11 Sebia SA

10.6.12 Recipe Chemicals & Instruments GmbH

10.6.13 Abionic SA

10.6.14 Metascreen Srl

10.6.15 PerkinElmer Genetics Inc.

10.6.16 Trivitron Healthcare Pvt. Ltd.

10.6.17 OZ Systems Inc.

10.6.18 Harmony Biosciences Holdings Inc.

10.6.19 Natera Inc.

10.6.20 Guardant Health Inc.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List of Tables

 14.2 List of Figures